285 related articles for article (PubMed ID: 20584274)
1. Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study.
Terhaar sive Droste JS; Oort FA; van der Hulst RW; Coupé VM; Craanen ME; Meijer GA; Morsink LM; Visser O; van Wanrooij RL; Mulder CJ
BMC Cancer; 2010 Jun; 10():332. PubMed ID: 20584274
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
4. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
8. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
9. The colorectal carcinoma prognosis factors. Significance of diagnosis delay.
Gómez-Domínguez E; Trapero-Marugán M; del Pozo AJ; Cantero J; Gisbert JP; Maté J
Rev Esp Enferm Dig; 2006 May; 98(5):322-9. PubMed ID: 16944992
[TBL] [Abstract][Full Text] [Related]
10. Effect of diagnostic delay on survival in patients with colorectal cancer: a retrospective cohort study.
Pita-Fernández S; González-Sáez L; López-Calviño B; Seoane-Pillado T; Rodríguez-Camacho E; Pazos-Sierra A; González-Santamaría P; Pértega-Díaz S
BMC Cancer; 2016 Aug; 16(1):664. PubMed ID: 27549406
[TBL] [Abstract][Full Text] [Related]
11. Time to diagnosis and stage of symptomatic colorectal cancer determined by three different sources of information: A population based retrospective study.
Leiva A; Esteva M; Llobera J; Macià F; Pita-Fernández S; González-Luján L; Sánchez-Calavera MA; Ramos M
Cancer Epidemiol; 2017 Apr; 47():48-55. PubMed ID: 28126583
[TBL] [Abstract][Full Text] [Related]
12. Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.
Pugh SA; Shinkins B; Fuller A; Mellor J; Mant D; Primrose JN
Ann Surg; 2016 Jun; 263(6):1143-7. PubMed ID: 26135689
[TBL] [Abstract][Full Text] [Related]
13. Impact of a colorectal cancer screening program implantation on delays and prognosis of non-screening detected colorectal cancer.
Cubiella J; Lorenzo M; Baiocchi F; Tejido C; Conde A; Sande-Meijide M; Castro M
World J Gastroenterol; 2021 Oct; 27(39):6689-6700. PubMed ID: 34754161
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer concealment predicts a poor survival: a retrospective study.
Li XP; Xie ZY; Fu YF; Yang C; Hao LP; Yang LM; Zhang MY; Li XL; Feng LL; Yan B; Sun Q
Asian Pac J Cancer Prev; 2013; 14(7):4157-60. PubMed ID: 23991969
[TBL] [Abstract][Full Text] [Related]
15. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer.
Korsgaard M; Pedersen L; Sørensen HT; Laurberg S
Cancer Detect Prev; 2006; 30(4):341-6. PubMed ID: 16965875
[TBL] [Abstract][Full Text] [Related]
16. Impact of the faecal immunochemical test on colorectal cancer survival.
Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
[TBL] [Abstract][Full Text] [Related]
17. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis.
Rupassara KS; Ponnusamy S; Withanage N; Milewski PJ
Colorectal Dis; 2006 Jun; 8(5):423-9. PubMed ID: 16684087
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
[TBL] [Abstract][Full Text] [Related]
19. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
[TBL] [Abstract][Full Text] [Related]
20. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.
Korsgaard M; Pedersen L; Sørensen HT; Laurberg S
Colorectal Dis; 2006 Oct; 8(8):688-95. PubMed ID: 16970580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
